Effects of Metformin With or Without Supplementation With Folate on Nomocysteine Levels and Vascular Endothelium of Women With Polycystic Ovary Syndrome

OBJECTIVE - To evaluate whether the administration Of metformin exerts any effects on serum homocysteine (Hcy) levels in Patients with polycystic ovary syndrome (PCOS) and whether supplementation with folate enhances the positive effects of metformin on the Structure and function of the vascular endothelium. RESEARCH DESIGN AND METHODS - A total of 50 patients affected by PCOS, without additional metabolic or cardiovascular diseases, were enrolled in a prospective nonrandomized placebo-con trolled double-blind clinical study. They were grouped into two treatment arms that were matched for age and BMI. Patients were treated with a 6-momh course of metformin (1,700 mg daily) plus folic acid (400 mu g daily; experimental group, n = 25) or placebo (control group, n = 25). Complete hormonal and Metabolic patterns, serum Hcy, folate, vitamin B12, endothelin-1 levels, brachial artery diameter at the baseline (BAD-B) and after reactive hyperemia (BAD-RH), flow-mediated dilation, and intima-media thickness in both common Carotid arteries were evaluated. RESULTS - After treatment, a significant increase in serum Hcy levels was observed in the control group compared with the baseline values and the experimental group. A beneficial effect was observed in the concentrations of BAD-B, BAD-RH, flow-mediated dilation, intima-media thickness, and serum endothelin-1 in both groups. However, the results were improved more significantly in the experimental group than in the control subjects. CONCLUSIONS - Metfomin exerts a slight but significant deleterious effect on serum Hey levels in patients with PCOS, and supplementation with folate is useful to increase the beneficial effect of metformin on the vascular endothelium.